Effects of integrated environmental intervention on prevention of worsening of allergic bronchopulmonary aspergillosis - ENVIPAS study

Japan Agency for Medical Research and Development0 个研究点目标入组 130 人开始时间: 2022年9月11日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients with Aspergillus-related lung disease other than ABPM (chronic pulmonary aspergillosis, etc.) 2. Patients with with cystic fibrosis 3. Those who plan to move from their current residence within one year of the scheduled start date of the research 4. Persons whose current residence is less than 1 year old from the scheduled start date of research 5. Those who do not have an air conditioner installed in the living room or the bedroom in their current residence. 6. The air conditioner in the living room and the bedroom in the current residence has been purchased or cleaned by a professional within one year of the scheduled start date of research. 7. Complete remission in the past 3 years; no treatment with oral steroids, antifungal drugs, or antibody drugs, no clinical symptoms or no abnormalities in the laboratory and radiographic tests 8. Patients who have received medium to high-dose oral steroid therapy (more than 10 mg/day equivalent to PSL for 14 days or more) within the past month 9. Patients who have newly started antifungal drug or biologics within the past 6 months

发起方